Document is current
Any future updates will be listed below
-
Authors
Gouda, Pishoy
Nelson, Adam J.
Raman, Sudha R.
Qualls, Laura G.
Hammill, Bradley G.
Garg, Jyotsna
Benziger, Catherine P.
Divakaran, Rekha
Nilles, Ester Kim
Marsolo, Keith
O’Brien, Emily C.
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 24 March 2026
First Online: 25 April 2026
Declarations
:
: Ethical approval was obtained from the Duke Institutional Review Board (PRO00104558).
: All authors have reviewed the manuscript and consent to its publication.
: PG, SRR, SRR, LGQ, BGH, JG, RD, EKN and ECOB report no disclosures. A.J.N. is a consultant for Amgen, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, GSK, Merck, Sanofi, and Novo Nordisk. Keith Marsolo reports grants and contracts to his institution from Novartis, Amgen, Seqirus, Genentech, BMS, Bayer, and Boehringer Ingelheim.
